Venous thromboembolism in viral diseases: A comprehensive literature review
Open Access
- 5 February 2023
- journal article
- review article
- Published by Wiley in Health Science Reports
- Vol. 6 (2) , e1085
Abstract
Venous thromboembolism (VTE) is known to be a common respiratory and/or cardiovascular complication in hospitalized patients with viral infections. Numerous studies have proven human immunodeficiency virus infection to be a prothrombotic condition. An elevated VTE risk has been observed in critically ill H1N1 influenza patients. VTE risk is remarkably higher in patients infected with the Hepatitis C virus in contrast to uninfected subjects. The elevation of D‐dimer levels supported the association between Chikungunya and the Zika virus and the rise of clinical VTE risk. Varicella‐zoster virus is a risk factor for both cellulitis and the consequent invasive bacterial disease which may take part in thrombotic initiation. Eventually, hospitalized patients infected with the coronavirus disease of 2019 (COVID‐19), the cause of the ongoing worldwide pandemic, could mainly suffer from an anomalous risk of coagulation activation with enhanced venous thrombosis events and poor quality clinical course. Although the risk of VTE in nonhospitalized COVID‐19 patients is not known yet, there are a large number of guidelines and studies on thromboprophylaxis administration for COVID‐19 cases. This study aims to take a detailed look at the effect of viral diseases on VTE, the epidemiology of VTE in viral diseases, and the diagnosis and treatment of VTE.Keywords
This publication has 301 references indexed in Scilit:
- Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung InjurymBio, 2013
- Increased Platelet and Microparticle Activation in HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Cancer Burden in the HIV-Infected Population in the United StatesJNCI: Journal of the National Cancer Institute, 2011
- Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV InfectionThe Journal of Infectious Diseases, 2010
- Endothelial Activation Markers Are Linked to HIV Status and Are Independent of Antiretroviral Therapy and LipoatrophyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Review: Thromboses among HIV-Infected Patients during the Highly Active Antiretroviral Therapy EraAIDS Patient Care and STDs, 2008
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006
- Endothelial Function in HIV-Infected PersonsClinical Infectious Diseases, 2006
- Severe Cytomegalovirus Infection in Immunocompetent PatientsClinical Infectious Diseases, 1997